NCT01808794

Brief Summary

The purpose of the study is to compare one material called "Mucograft" with another material called "Dynamatrix." These materials are used as a type of a barrier (made from pig material also known as porcine material) in a preservation technique to increase the thickness and width of tissues at a tooth extraction site. The investigators want to see if one works better than the other or if they work equally as well. These materials are made up of collagens, which are naturally occurring proteins found in the skin, specifically connective tissue. Dynamatrix is made up of many types of collagens whereas Mucograft is only made of fewer collagens. These materials have been given something called a 510(k) status by the FDA. This means that the FDA determines them to be equivalent to another product that they have previously approved. You will be put into one of two groups at random, and will not know which one you are in. Like flipping a coin, you will have a 50/50 chance to be in either one of the two groups. You will either be in a group using Mucograft or in a group using Dynamatrix. Both of these materials are regularly used in the dental clinics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
4.1 years until next milestone

Results Posted

Study results publicly available

February 19, 2020

Completed
Last Updated

February 19, 2020

Status Verified

February 1, 2020

Enrollment Period

3 years

First QC Date

March 5, 2013

Results QC Date

February 10, 2020

Last Update Submit

February 10, 2020

Conditions

Keywords

membranesMucograftDynamatrixwridgepreservationboneallograftextractionsitehealing

Outcome Measures

Primary Outcomes (1)

  • Compare Barrier Membranes by Examining Keratinized Tissue

    The primary aim is to compare MucograftTM when used as a barrier membrane in the ridge preservation technique to increase or preserve the thickness and width of keratinized tissue at the extraction site in comparison to DynamatrixTM.

    4-6 Months after surgical procedure

Secondary Outcomes (1)

  • Alveolar Bone Height

    4-6 Months after surgical procedure

Study Arms (2)

Mucograft

ACTIVE COMPARATOR

Placement of randomized membrane on half of subjects Mucograft

Device: Mucograft

Dynamatrix

ACTIVE COMPARATOR

Placement of randomized membrane on half of subjects Dynamatrix Membrane Placement

Device: Dynamatrix

Interventions

MucograftDEVICE

Mucograft Collagen Matrix

Also known as: 510(k) #K073711
Mucograft

Dynamatrix

Also known as: 510(k) #K082058
Dynamatrix

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be at least 18 years of age.
  • Have unsalvageable non-adjacent non-molar teeth: maxillary incisors, canines, and premolars, and mandibular canines and premolars that require an extraction with bone augmentation planned for delayed implant placement. If a subject has multiple teeth to be extracted, only one tooth will be included in the study.
  • Patients who are currently treatment planned in the Tufts University School of Dental Medicine (TUSDM) periodontology clinic to receive bone augmentation and delayed implant placement and meet all medical and dental requirements of the TUSDM periodontology clinic for periodontal surgery (e.g., subjects with no diseases or medication allergies contraindicating periodontal surgery).
  • Display no evidence of acute periodontal infection: e.g., abscess, suppuration, severe swelling and/or spontaneous bleeding.
  • Smoke less than 10 cigarettes per day.
  • Not participating in any other dental research study for the duration of this study.

You may not qualify if:

  • Have any known disease that interferes with periodontal surgery and would not allow the patient to be treatment planned for the procedures in the TUSDM periodontology clinic (e.g., severe anemia, low white blood cell count, bleeding or coagulation disorder, uncontrolled hypertension, recent myocardial infarction (within 6 months of enrollment), poorly controlled diabetes, HIV/AIDS (self-reported), history of or currently undergoing head and neck radiation, history of or currently taking bisphosphonates).
  • Have a history of severe psychological conditions or limited mental capacity.
  • Be a pregnant or lactating female (self-reported) (following TUSDM periodontology clinic guidelines elective surgical procedures and radiographs/CBCT scans are usually postponed until after delivery).
  • Individuals opposed to having porcine derived materials placed in their mouth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

Location

Results Point of Contact

Title
Associate Vice Provost for Research Administration & Development
Organization
Tufts University

Study Officials

  • James Hanley, DMD

    TUSDM

    PRINCIPAL INVESTIGATOR
  • Youngsoo Kim, DDS

    TUSDM

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2013

First Posted

March 11, 2013

Study Start

January 1, 2013

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

February 19, 2020

Results First Posted

February 19, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations